SEC filings
Email alerts
Fill out the form below to receive real-time email notifications for select financial press releases, and SEC filings.
Sign up for alerts
Latest news
Monrovia, CA -- February 21, 2025 -- eXoZymes Inc. (NASDAQ: EXOZ, formerly Invizyne Technologies) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential chemicals, medicines, and biofuels - and MDB Capital Holdings (NASDAQ: MDBH) - a premier venture platform for breakthrough technology companies - today announced key leadership changes within the eXoZymes board of directors.